Lung Cancer

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.

The FDA approved osimertinib for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

Researchers studied bronchial and nasal epithelial gene expression to see if lung damage related to smoking was detectable via nasal tissue swab.

The research presented at the International Association for the Study of Lung Cancer examined the relationship between nonsteroidal anti-inflammatory drugs and the risk of lung cancer using the data from...

A retrospective study found that new criteria for classifying lung nodules may substantially reduce the false-positive result rate in lung cancer screening.